Literature DB >> 17703388

Risk factors for complication following ERCP; results of a large-scale, prospective multicenter study.

E J Williams1, S Taylor, P Fairclough, A Hamlyn, R F Logan, D Martin, S A Riley, P Veitch, M L Wilkinson, P R Williamson, M Lombard.   

Abstract

BACKGROUND AND STUDY AIMS: Analyses of endoscopic retrograde cholangiopancreatography (ERCP) complication are often constrained by the number of endpoints observed. This large-scale study aimed to identify the principal risk factors for ERCP complication. PATIENTS AND METHODS: This was a prospective multicenter study of ERCP complications, based in five English regions. An exploratory univariable analysis of patients' first recorded procedures identified potentially important patient- and procedure-related factors. For overall complications and pancreatitis, variables significant in univariable analysis were included in multiple regression.
RESULTS: A total of 66 centers collected data on 5264 ERCPs, performed on 4561 patients. A therapeutic intervention was attempted in 3447/4561 (76%) of patients as part of their first recorded ERCP. Following first recorded ERCP, 230 patients (5.0%) suffered > or = 1 complication: pancreatitis in 74 (1.6%), cholangitis in 48 (1.0 %), hemorrhage in 40 (0.9%), perforation in 20 (0.4%), and miscellaneous in 54 (1.2%). Significant factors from multiple regression were included in a multi-level analysis, which incorporated variables measured at the level of the endoscopist and hospital. For overall complication, risk factors ( P value, odds ratio [OR], 95% confidence interval [CI]) were: cannulation attempts > 1 ( P = 0.094, OR 1.32, 95% CI 0.95-1.83), precut ( P = 0.033, OR 1.55, 95 % CI 1.04-2.32), and suspected sphincter of Oddi dysfunction ( P = 0.121, OR 1.97, 95 % CI 0.84-4.64). For pancreatitis, risk factors ( Pvalue, OR, and 95 % CI) were: cannulation attempts > 1 ( P = 0.0001, OR 3.14, 95% CI 1.74-5.67), female sex ( P < 0.001, OR 2.22, 95% CI 1.43-3.45), age ( P < 0.002, OR 1.09 per 5 year decrease, 95% CI 1.03-1.15), and performance in a district (as opposed to university) hospital ( P = 0.034, OR 2.41, 95% CI 1.08-5.41).
CONCLUSION: Careful patient selection combined with skilled cannulation minimizes complications. Higher-risk procedures should be performed in specialist centers.

Entities:  

Mesh:

Year:  2007        PMID: 17703388     DOI: 10.1055/s-2007-966723

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  101 in total

Review 1.  Endoscopic complications--avoidance and management.

Authors:  Daniel Blero; Jacques Devière
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-14       Impact factor: 46.802

2.  Dietary approaches following endoscopic retrograde cholangiopancreatography: A survey of selected endoscopists.

Authors:  Lincoln Evvc Ferreira; Mark D Topazian; William S Harmsen; Alan R Zinsmeister; Todd H Baron
Journal:  World J Gastrointest Endosc       Date:  2010-12-16

3.  Incidence of delayed complications following percutaneous CT-guided biopsy of bone and soft tissue lesions of the spine and extremities: a 2-year prospective study and analysis of risk factors.

Authors:  Ambrose J Huang; Elkan F Halpern; Daniel I Rosenthal
Journal:  Skeletal Radiol       Date:  2012-05-22       Impact factor: 2.199

4.  The impact of prophylactic pancreatic stenting on post-ERCP pancreatitis: A nationwide, register-based study.

Authors:  Greger Olsson; Jeanne Lübbe; Urban Arnelo; Eduard Jonas; Björn Törnqvist; Lars Lundell; Lars Enochsson
Journal:  United European Gastroenterol J       Date:  2016-07-08       Impact factor: 4.623

Review 5.  [Importance of endoscopy and endosonography for chronic pancreatitis and benign pancreas tumors].

Authors:  M Fuchs; W Schepp
Journal:  Radiologe       Date:  2008-08       Impact factor: 0.635

Review 6.  Minimizing complications in pancreaticobiliary endoscopy.

Authors:  Olga Barkay; Mouen Khashab; Mohammad Al-Haddad; Evan L Fogel
Journal:  Curr Gastroenterol Rep       Date:  2009-04

Review 7.  Balloon dilation itself may not be a major determinant of post-endoscopic retrograde cholangiopancreatography pancreatitis.

Authors:  Sung Ill Jang; Gak Won Yun; Dong Ki Lee
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

8.  Prophecy about post-endoscopic retrograde cholangiopancreatography pancreatitis: from divination to science.

Authors:  Sung-Hoon Moon; Myung-Hwan Kim
Journal:  World J Gastroenterol       Date:  2013-02-07       Impact factor: 5.742

9.  Safety and Efficacy of Acute Endoscopic Retrograde Cholangiopancreatography in the Elderly.

Authors:  Mika Ukkonen; Antti Siiki; Anne Antila; Tuula Tyrväinen; Juhani Sand; Johanna Laukkarinen
Journal:  Dig Dis Sci       Date:  2016-08-26       Impact factor: 3.199

10.  Risk models for post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP): smoking and chronic liver disease are predictors of protection against PEP.

Authors:  Matthew J DiMagno; Joshua P Spaete; Darren D Ballard; Erik-Jan Wamsteker; Sameer D Saini
Journal:  Pancreas       Date:  2013-08       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.